UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Monitoring expenses reveals patterns like recurring charges or impulsive buys. Look for spikes, then adjust categories to optimize your plan.
17,195 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Considering your first rental property means weighing local comfort against the pull of ambitious markets. This guide...
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Celebrities set fashion moments at weddings, but personal finance matters behind the scenes. Learn how to evaluate hi...
Looking for reliable, income-generating investments you can hold for decades? This guide picks three dividend stocks ...
A single earnings report is not the end of a story, but it can rewrite it. This article explains how Micron's latest ...
A retiree explores how a $475,000 portfolio that quietly pays $2,800 a month relies on two overlooked income sources....
Investors face a clear choice between two CRM juggernauts. This guide breaks down HubSpot and Salesforce, weighing gr...
As e.l.f. Beauty moves into 2026, investors want clarity on growth drivers and risk. This guide breaks down the Q4 ou...
Investors are debating whether d-wave's opportunity flag? marks a breakthrough or a trap. This guide breaks down the ...
A new wave of AI-enabled lending could be headed for auto loans. This article explains why upstart's auto loan push m...